| Literature DB >> 25258530 |
Jie Gao1, Jun-Fa Xue2, Meng Xu2, Bao-Song Gui1, Feng-Xin Wang2, Jian-Ming Ouyang2.
Abstract
class="abstract_title">PURPOSE: This study aimed to accEntities:
Keywords: EDS; HRTEM; calcium oxalate stones; heterogeneous nucleation; nanocrystallites
Mesh:
Substances:
Year: 2014 PMID: 25258530 PMCID: PMC4172125 DOI: 10.2147/IJN.S66000
Source DB: PubMed Journal: Int J Nanomedicine ISSN: 1176-9114
Comparison of properties of urine from healthy controls and CaOx stone-forming patients (n=9)
| Particulars | Healthy controls (n=9), mean ± SD | CaOx stone-forming patients (n=9), mean ± SD | |
|---|---|---|---|
| Urine volume, mL/day | 1,713±378 | 1,213±202 | <0.05 |
| Urine pH | 6.09±0.27 | 6.31±0.23 | NS |
| Calcium, mg/L | 112±14 | 147±32 | <0.05 |
| Oxalate, mg/L | 20.1±3.0 | 35.2±5.11 | <0.05 |
| Phosphorous, mg/L | 441±59 | 481±89 | NS |
| Uric acid excretion, mg/L | 496±128 | 741±203 | <0.01 |
| Citrate excretion, mg/L | 341±81 | 236±56 | <0.05 |
| GAGs excretion, mg/L | 9.33±2.90 | 4.32±2.04 | <0.01 |
| Magnesium, mg/L | 61.0±14.8 | 71.1±14.2 | <0.05 |
| Creatinine, mg/L | 909±188 | 1,069±169 | NS |
| Zeta potential, mV | −(10.2±2.0) | −(6.09±1.91) | <0.01 |
Note:
Data were analyzed using a Student’s t-test.
Abbreviations: SD, standard deviation; CaOx, calcium oxalate; GAG, glycosaminoglycan; NS, not significant.
Figure 1X-ray diffraction spectra of stones in two representative calcium oxalate stone patients.
Notes: (A) patient A, (B) patient B. apeak at d=2.26 (202), bpeak at d=2.24 (213). The black arrows indicate the corresponding peaks and crystal faces. ★calcium oxalate monohydrate, ✰calcium oxalate dihydrate.
Figure 2High-resolution transmission electron microscopy images of urinary nanocrystallites of two representative calcium oxalate stone patients.
Notes: (A) Patient A, the bar: 500 nm; (B) patient B, the bar: 200 nm.
Figure 3Fast Fourier transformation (FFT) images of high-resolution transmission electron microscopy in different areas of urinary nanocrystallites in one representative calcium oxalate stone patient.
Notes: (A–D) show patients A–D, respectively. a and b show the FFT diffraction patterns transformed from the respective yellow boxes in A.
Abbreviation: d, interplanar spacing.
Figure 4Selected area electron diffraction images in different areas of urinary crystallites in one patient with calcium oxalate stones.
Note: (A) patient D, (B) patient A.
Abbreviation: d, interplanar spacing.
High-resolution transmission electron microscopy diffraction data and attributes in different areas of urinary crystallites in patients with calcium oxalate stones
| Measured | Attribution | ||
|---|---|---|---|
| a | (0210) plane of β-CaP | ||
| b | (517) plane of β-CaP | ||
| c | (1,514) plane of β-CaP | ||
| a | (
| ||
| b | (220) plane of β-CaP | ||
| c | (404) plane of β-CaP | ||
| d | (
| ||
| e | (2,218) plane of β-CaP | ||
| f | (517) plane of β-CaP | ||
Note: (A) data from patient D, (B) data from patient A. (a–f) The different interplanar spacings of urinary crystallites.
Abbreviations: CaP, calcium phosphate; COM, calcium oxalate monohydrate; d, crystal plane distance; PDF, powder diffraction file.
Figure 5High-resolution transmission electron microscopy and selected area electron diffraction images of urinary nanocrystallites of one representative calcium oxalate stone patient. The bar: (A) 100 nm, (B) 10 nm, (C) 5 nm, (D) 2 1/nm.
Notes: The areas B, C, and D in (A) are enlarged in (B), (C), and (D), respectively. a and b show the FFT diffraction patterns transformed from the respective yellow boxes in B.
Abbreviations: CaP, calcium phosphate; COM, calcium oxalate monohydrate; d, interplanar spacing.
Figure 6Atomic ratios from energy dispersive X-ray spectroscopy analysis of the central and surrounding regions of different urinary crystallites from calcium oxalate monohydrate stone patients.
Figure 7Energy dispersive X-ray spectroscopy analysis of the elemental distribution of urinary crystallite of a representative calcium oxalate stone patient.
Notes: (A, C) High-resolution transmission electron microscopy images; (B, D) element distribution, in which (A, B) show the central part, and (C, D) show the outside part of urinary crystallites.
Figure 8Schema of the process of papillary COM renal stone formation.
Abbreviations: CaP, calcium phosphate; COM, calcium oxalate monohydrate; GAGs, glycosaminoglycans; UA, uric acid.